Champions Oncology, Inc.
CSBR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000771856
No open-market purchases or sales by Champions Oncology, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $36.3M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Champions Oncology, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −3 vs. Q2 2021
- Shares held
- 6.28M
- −377.2K (−5.7%) vs. Q2 2021
- Total value
- $64.1M
- −$4.34M (−6.3%) vs. Q2 2021
- New holders
- 2
- 8 more added
- Sold out
- 5
- 17 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CSBR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $36.3M |
| Q1 2026 | 25 | $33.0M |
| Q4 2025 | 27 | $39.7M |
| Q3 2025 | 27 | $36.7M |
| Q2 2025 | 30 | $42.5M |
| Q1 2025 | 34 | $51.4M |
| Q4 2024 | 25 | $49.0M |
| Q3 2024 | 22 | $28.2M |
| Q2 2024 | 23 | $29.9M |
| Q1 2024 | 25 | $27.6M |
| Q4 2023 | 23 | $31.5M |
| Q3 2023 | 29 | $35.6M |
| Q2 2023 | 28 | $37.0M |
| Q1 2023 | 30 | $23.6M |
| Q4 2022 | 29 | $27.1M |
| Q3 2022 | 32 | $46.8M |
| Q2 2022 | 32 | $49.8M |
| Q1 2022 | 30 | $50.4M |
| Q4 2021 | 31 | $51.7M |
| Q3 2021 | 35 | $64.1M |
| Q2 2021 | 38 | $68.5M |
| Q1 2021 | 45 | $81.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Champions Oncology, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Battery Management Corp. | 2,421,673 | $24.7M | 1.15% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,713,720 | $17.5M | 0.22% | 00.0% | Unchanged |
| Vanguard Group Inc | 327,636 | $3.35M | 0.00% | 00.0% | Unchanged |
| Millrace Asset Group, Inc. | 324,075 | $3.31M | 2.07% | +43,636+15.6% | Added |
| Tocqueville Asset Management L.P. | 252,461 | $2.58M | 0.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 221,146 | $2.26M | 0.00% | −6,900−3.0% | Reduced |
| BlackRock Inc. | 122,398 | $1.25M | 0.00% | +15,376+14.4% | Added |
| Dimensional Fund Advisors LP | 119,902 | $1.22M | 0.00% | −10,753−8.2% | Reduced |
| Bank of Montreal | 97,903 | $1.02M | 0.00% | −5,031−4.9% | Reduced |
| Essex Investment Management Co LLC | 89,507 | $914.0K | 0.11% | −1,617−1.8% | Reduced |
| Overbrook Management Corp | 81,507 | $832.0K | 0.18% | −13,433−14.1% | Reduced |
| Millennium Management LLC | 60,411 | $617.0K | 0.00% | −27,899−31.6% | Reduced |
| ACT Capital Management, LLC | 58,500 | $597.0K | 0.31% | +8,500+17.0% | Added |
| ClariVest Asset Management LLC | 56,300 | $575.0K | 0.02% | −300−0.5% | Reduced |
| Geode Capital Management, LLC | 47,638 | $486.0K | 0.00% | +4,685+10.9% | Added |
| Aristides Capital LLC | 36,750 | $375.0K | 0.28% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 31,476 | $320.0K | 0.00% | −10.0% | Reduced |
| Bank of New York Mellon Corp | 30,775 | $314.0K | 0.00% | −21,050−40.6% | Reduced |
| Ergoteles LLC | 30,565 | $312.0K | 0.01% | −335−1.1% | Reduced |
| Susquehanna Fundamental Investments, LLC | 28,382 | $290.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 27,868 | $285.0K | 0.00% | +149+0.5% | Added |
| HighTower Advisors, LLC | 26,467 | $270.0K | 0.00% | +7,040+36.2% | Added |
| State Street Corp | 24,563 | $251.0K | 0.00% | +400+1.7% | Added |
| HRT Financial LP | 12,541 | $128.0K | 0.00% | −2,426−16.2% | Reduced |
| Ingalls & Snyder LLC | 11,056 | $113.0K | 0.01% | 00.0% | Unchanged |
| Globeflex Capital L P | 8,549 | $87.0K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 6,925 | $70.0K | 0.00% | −12,913−65.1% | Reduced |
| Federated Hermes, Inc. | 5,894 | $59.0K | 0.00% | +5,894 | New |
| Barclays PLC | 818 | $8.00K | 0.00% | −28−3.3% | Reduced |
| Total Clarity Wealth Management, Inc. | 713 | $7.00K | 0.00% | +713 | New |
| Royal Bank of Canada | 125 | $1.00K | 0.00% | −1,229−90.8% | Reduced |
| Tower Research Capital LLC (TRC) | 117 | $1.00K | 0.00% | −558−82.7% | Reduced |
| BNP Paribas Arbitrage, SA | 45 | $459 | 0.00% | −1,429−96.9% | Reduced |
| JPMorgan Chase & Co | 11 | $0 | 0.00% | −4,368−99.7% | Reduced |
| Wells Fargo & Company | 40 | $0 | 0.00% | +4+11.1% | Added |
| Roubaix Capital, LLC | 0 | $0 | 0.00% | −351,507−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,430−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −278−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −76−100.0% | Sold out |